Ras-like GTPase-effector protein interface (Ral-effector interface)

The Ras-like (Ral) GTPase-effector protein interface represents a critical signaling node in the Ras pathway, comprising the physical interaction sites between RalA or RalB and their downstream effectors such as RalBP1 (RLIP76) and the exocyst components Sec5 and Exo84. Ral GTPases function as molecular switches that, when activated by Ras-regulated guanine nucleotide exchange factors (RalGEFs), bind to these effectors to regulate diverse cellular processes including vesicle trafficking, migration, and survival. In many human malignancies, particularly those driven by KRAS mutations like pancreatic and lung cancers, the Ral pathway is hyperactivated and essential for tumor growth and metastasis. Because the Ral proteins themselves lack traditional small-molecule binding pockets, therapeutic strategies have shifted toward targeting the protein-protein interface (PPI) between Ral and its effectors. Small molecule inhibitors like RBC8 and BQU57 have been developed to bind into a cavity on the surface of GTP-bound Ral, sterically hindering effector recruitment and effectively suppressing oncogenic signaling in preclinical models.

Other names

Ral-effector protein interaction siteRal-RalBP1 interfaceRal-exocyst interfaceRalA/B-effector interface

Inhibition of protein-protein interaction (PPI) between active GTP-bound Ral proteins and downstream effectors such as RalBP1 or the exocyst complex.